Filing Details

Accession Number:
0000899243-16-021835
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-06-06 18:04:48
Reporting Period:
2016-06-03
Filing Date:
2016-06-06
Accepted Time:
2016-06-06 18:04:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1596946 Quotient Ltd QTNT In Vitro & In Vivo Diagnostic Substances (2835) 264719797
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1604630 Stephen Unger Elizabeth House, 9 Castle Street
St Helier Y9 JE2 3RT
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2016-06-03 14,484 $9.99 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Ordinary Shares Employee Stock Option (right to buy) $11.92 2026-05-31 15,000 15,000 Direct
Ordinary Shares Multi-year Performance Based Restricted Stock Units $0.00 2018-12-31 15,000 15,000 Direct
Ordinary Shares Multi-year Performance Based Restricted Stock Units $0.00 2018-12-31 22,500 22,500 Direct
Ordinary Shares Employee Stock Option (right to buy) $15.17 2025-05-19 22,500 22,500 Direct
Ordinary Shares Employee Stock Option (right to buy) $8.00 2024-04-29 50,800 50,800 Direct
Ordinary Shares Options to Purchase Ordinary shares $8.00 2024-03-03 67,200 67,200 Direct
Ordinary Shares Options to Purchase Ordinary shares $3.29 2023-06-27 32,000 32,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2026-05-31 15,000 15,000 Direct
2018-12-31 15,000 15,000 Direct
2018-12-31 22,500 22,500 Direct
2025-05-19 22,500 22,500 Direct
2024-04-29 50,800 50,800 Direct
2024-03-03 67,200 67,200 Direct
2023-06-27 32,000 32,000 Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.85 to $10.28, inclusive. The Reporting Person undertakes to provide Quotient, any security holder of Quotient, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
  2. The options will vest and become exercisable in three equal annual installments beginning on June 1, 2017.
  3. Each Multi-year Performance Based Restricted Stock Unit ("MRSU") represents a contingent right to receive one share of Quotient's ordinary shares. The MRSUs vest upon Quotient's ordinary shares achieving a volume weighted average market price of $40.00 per share for 20 consecutive trading days during the period April 1, 2018 to December 31, 2018.
  4. Each MRSU represents a contingent right to receive one share of Quotient's ordinary shares. The MRSUs vest upon Quotient's ordinary shares achieving a volume weighted average market price of $60.00 per share for 20 consecutive trading days during the period April 1, 2018 to December 31, 2018.
  5. 7,500 options vested on 5/20/2016 and remain exercisable, 7,500 will vest on 5/20/2017, 7,500 will vest on 5/20/2018.
  6. 33,866 options have vested and remain exercisable, 16,934 options will vest on 4/29/2017.
  7. 44,800 options have vested and remain exercisable, 22,400 options will vest on 3/4/2017.
  8. 21,334 options have vested and remain exercisable, 10,666 options will vest on 6/28/2016.